glp-1 cardiovascular outcomes trial august 2025 Effects and Tolerability of Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients GLP-1 medications are not just

Snaith JR, Holmes-Walker DJ, Greenfield JR (2020) Reducing type 1 diabetes mortality: role for adjunctive therapies

Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1 in a Mouse Model of Parkinson's Disease

d PIONEER, 6 was designed to document cardiovascular safety only

Some studies even reported lower incidence of cancer, including colorectal, liver, prostate and endometrial cancers, said Wellberg, an assistant professor in the OU College of Medicine and research member of OU Health Stephenson Cancer Center

FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing

Before you dive deeper, build a personal checklist that fits your habits and risk tolerance